Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Sandmann

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Journal of Hepatology|April 16, 2025
Toward functional cure of hepatitis B: Is combination therapy the key?Lisa Sandmann
Journal of Hepatology|January 20, 2026
Tobevibart and elebsiran for the treatment of chronic hepatitis deltaLisa Sandmann
Journal of Hepatology|August 1, 2025
From HCV to HEV: Repurposing a nucleoside analogue for hepatitis E therapyLisa Sandmann
Journal of Hepatology|January 21, 2025
Antiviral treatment of chronic hepatitis D virus infection: To combine or not to combine?Lisa Sandmann
Journal of Hepatology|November 20, 2025
The identification of interleukin-27 as one key player in restoring virus-specific T-cell dysfunction in chronic hepatitis B virus infectionLisa Sandmann
Hepatology (Baltimore, Md.)|January 10, 2022
HCC and HBV reactivation-A preventable condition not to be missedLisa Sandmann, Markus Cornberg
Journal of Experimental Pharmacology|April 23, 2021
Experimental Drugs for the Treatment of Hepatitis DLisa Sandmann, Markus Cornberg
Deutsche Medizinische Wochenschrift (1946)|October 10, 2025
[Screening and Prevention of Chronic Viral Hepatitis]Markus Cornberg, Lisa Sandmann
Liver International : Official Journal of the International Association for the Study of the Liver|August 24, 2022
Interferon-based treatment of chronic hepatitis DLisa Sandmann, Heiner Wedemeyer
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2023
HBV cure-The light at the end of the tunnel?Lisa Sandmann, Benjamin Maasoumy
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Journal of Hepatology|April 16, 2025
Toward functional cure of hepatitis B: Is combination therapy the key?Lisa Sandmann
Journal of Hepatology|January 20, 2026
Tobevibart and elebsiran for the treatment of chronic hepatitis deltaLisa Sandmann
Journal of Hepatology|August 1, 2025
From HCV to HEV: Repurposing a nucleoside analogue for hepatitis E therapyLisa Sandmann
Journal of Hepatology|January 21, 2025
Antiviral treatment of chronic hepatitis D virus infection: To combine or not to combine?Lisa Sandmann
Journal of Hepatology|November 20, 2025
The identification of interleukin-27 as one key player in restoring virus-specific T-cell dysfunction in chronic hepatitis B virus infectionLisa Sandmann
Hepatology (Baltimore, Md.)|January 10, 2022
HCC and HBV reactivation-A preventable condition not to be missedLisa Sandmann, Markus Cornberg
Journal of Experimental Pharmacology|April 23, 2021
Experimental Drugs for the Treatment of Hepatitis DLisa Sandmann, Markus Cornberg
Deutsche Medizinische Wochenschrift (1946)|October 10, 2025
[Screening and Prevention of Chronic Viral Hepatitis]Markus Cornberg, Lisa Sandmann
Liver International : Official Journal of the International Association for the Study of the Liver|August 24, 2022
Interferon-based treatment of chronic hepatitis DLisa Sandmann, Heiner Wedemeyer
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2023
HBV cure-The light at the end of the tunnel?Lisa Sandmann, Benjamin Maasoumy
Pageof 6